Literature DB >> 34514530

Educational level as a cause of type 2 diabetes mellitus: Caution from triangulation of observational and genetic evidence.

Nat Na-Ek1,2, Juthamanee Srithong3, Authakorn Aonkhum3, Suthida Boonsom3,4, Pimphen Charoen5,6, Panayotes Demakakos7.   

Abstract

BACKGROUND AND
OBJECTIVE: Education might be causal to type 2 diabetes mellitus (T2DM). We triangulated cohort and genetic evidence to consolidate the causality between education and T2DM.
METHODS: We obtained observational evidence from the English Longitudinal Study of Ageing (ELSA). Self-reporting educational attainment was categorised as high (post-secondary and higher), middle (secondary), and low (below secondary or no academic qualifications) in 6,786 community-dwelling individuals aged ≥ 50 years without diabetes at ELSA wave 2, who were followed until wave 8 for the first diabetes diagnosis. Additionally, we performed two-sample Mendelian randomisation (MR) using an inverse-variance weighted (IVW), MR-Egger, weighted median (WM), and weighted mode-based estimate (WMBE) method. Steiger filtering was further applied to exclude single-nucleotide polymorphisms (SNPs) that were correlated with an outcome (T2DM) stronger than exposure (education attainment).
RESULTS: We observed 598 new diabetes cases after 10.4 years of follow-up. The adjusted hazard ratios (95% CI) of T2DM were 1.20 (0.97-1.49) and 1.58 (1.28-1.96) in the middle- and low-education groups, respectively, compared to the high-education group. Low education was also associated with increased glycated haemoglobin levels. Psychosocial resources, occupation, and health behaviours fully explained these inverse associations. In the MR analysis of 210 SNPs (R2 = 0.0161), the odds ratio of having T2DM per standard deviation-decreasing years (4.2 years) of schooling was 1.33 (1.01-1.75; IVW), 1.23 (0.37-4.17; MR-Egger), 1.56 (1.09-2.27; WM), and 2.94 (0.98-9.09; WMBE). However, applying Steiger filtering attenuated most MR results towards the null.
CONCLUSIONS: Our inconsistent findings between cohort and genetic evidence did not support the causality between education and T2DM.
© 2021. Springer-Verlag Italia S.r.l., part of Springer Nature.

Entities:  

Keywords:  Educational level; Glycated haemoglobin; Mendelian randomisation; Prospective cohort; Type 2 diabetes mellitus

Mesh:

Year:  2021        PMID: 34514530      PMCID: PMC8968222          DOI: 10.1007/s00592-021-01795-7

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  34 in total

1.  Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure.

Authors:  Yuji Okura; Lynn H Urban; Douglas W Mahoney; Steven J Jacobsen; Richard J Rodeheffer
Journal:  J Clin Epidemiol       Date:  2004-10       Impact factor: 6.437

2.  Trends in the incidence of diagnosed diabetes: a multicountry analysis of aggregate data from 22 million diagnoses in high-income and middle-income settings.

Authors:  Dianna J Magliano; Lei Chen; Rakibul M Islam; Bendix Carstensen; Edward W Gregg; Meda E Pavkov; Linda J Andes; Ran Balicer; Marta Baviera; Elise Boersma-van Dam; Gillian L Booth; Juliana C N Chan; Yi Xian Chua; Sandrine Fosse-Edorh; Sonsoles Fuentes; Hanne L Gulseth; Romualdas Gurevicius; Kyoung Hwa Ha; Thomas R Hird; György Jermendy; Mykola D Khalangot; Dae Jung Kim; Zoltán Kiss; Victor I Kravchenko; Maya Leventer-Roberts; Chun-Yi Lin; Andrea O Y Luk; Manel Mata-Cases; Didac Mauricio; Gregory A Nichols; Mark M Nielen; Deanette Pang; Sanjoy K Paul; Catherine Pelletier; Santa Pildava; Avi Porath; Stephanie H Read; Maria Carla Roncaglioni; Paz Lopez-Doriga Ruiz; Marina Shestakova; Olga Vikulova; Kang-Ling Wang; Sarah H Wild; Naama Yekutiel; Jonathan E Shaw
Journal:  Lancet Diabetes Endocrinol       Date:  2021-02-23       Impact factor: 32.069

3.  Mendelian randomization: using genes as instruments for making causal inferences in epidemiology.

Authors:  Debbie A Lawlor; Roger M Harbord; Jonathan A C Sterne; Nic Timpson; George Davey Smith
Journal:  Stat Med       Date:  2008-04-15       Impact factor: 2.373

4.  Socioeconomic status and incident type 2 diabetes mellitus: data from the Women's Health Study.

Authors:  Timothy C Lee; Robert J Glynn; Jessica M Peña; Nina P Paynter; David Conen; Paul M Ridker; Aruna D Pradhan; Julie E Buring; Michelle A Albert
Journal:  PLoS One       Date:  2011-12-14       Impact factor: 3.240

5.  Social inequalities in prevalence of diagnosed and undiagnosed diabetes and impaired glucose regulation in participants in the Health Surveys for England series.

Authors:  Alison Moody; Giovanna Cowley; Linda Ng Fat; Jennifer S Mindell
Journal:  BMJ Open       Date:  2016-02-08       Impact factor: 2.692

6.  Adulthood Socioeconomic Position and Type 2 Diabetes Mellitus-A Comparison of Education, Occupation, Income, and Material Deprivation: The Maastricht Study.

Authors:  Yuwei Qi; Annemarie Koster; Martin van Boxtel; Sebastian Köhler; Miranda Schram; Nicolaas Schaper; Coen Stehouwer; Hans Bosma
Journal:  Int J Environ Res Public Health       Date:  2019-04-23       Impact factor: 3.390

7.  Genome-wide analysis of health-related biomarkers in the UK Household Longitudinal Study reveals novel associations.

Authors:  Bram P Prins; Karoline B Kuchenbaecker; Yanchun Bao; Melissa Smart; Delilah Zabaneh; Ghazaleh Fatemifar; Jian'an Luan; Nick J Wareham; Robert A Scott; John R B Perry; Claudia Langenberg; Michaela Benzeval; Meena Kumari; Eleftheria Zeggini
Journal:  Sci Rep       Date:  2017-09-08       Impact factor: 4.379

8.  Guidelines for performing Mendelian randomization investigations.

Authors:  Stephen Burgess; George Davey Smith; Neil M Davies; Frank Dudbridge; Dipender Gill; M Maria Glymour; Fernando P Hartwig; Michael V Holmes; Cosetta Minelli; Caroline L Relton; Evropi Theodoratou
Journal:  Wellcome Open Res       Date:  2020-04-28

9.  Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes.

Authors:  Andrew P Morris; Benjamin F Voight; Tanya M Teslovich; Teresa Ferreira; Ayellet V Segrè; Valgerdur Steinthorsdottir; Rona J Strawbridge; Hassan Khan; Harald Grallert; Anubha Mahajan; Inga Prokopenko; Hyun Min Kang; Christian Dina; Tonu Esko; Ross M Fraser; Stavroula Kanoni; Ashish Kumar; Vasiliki Lagou; Claudia Langenberg; Jian'an Luan; Cecilia M Lindgren; Martina Müller-Nurasyid; Sonali Pechlivanis; N William Rayner; Laura J Scott; Steven Wiltshire; Loic Yengo; Leena Kinnunen; Elizabeth J Rossin; Soumya Raychaudhuri; Andrew D Johnson; Antigone S Dimas; Ruth J F Loos; Sailaja Vedantam; Han Chen; Jose C Florez; Caroline Fox; Ching-Ti Liu; Denis Rybin; David J Couper; Wen Hong L Kao; Man Li; Marilyn C Cornelis; Peter Kraft; Qi Sun; Rob M van Dam; Heather M Stringham; Peter S Chines; Krista Fischer; Pierre Fontanillas; Oddgeir L Holmen; Sarah E Hunt; Anne U Jackson; Augustine Kong; Robert Lawrence; Julia Meyer; John R B Perry; Carl G P Platou; Simon Potter; Emil Rehnberg; Neil Robertson; Suthesh Sivapalaratnam; Alena Stančáková; Kathleen Stirrups; Gudmar Thorleifsson; Emmi Tikkanen; Andrew R Wood; Peter Almgren; Mustafa Atalay; Rafn Benediktsson; Lori L Bonnycastle; Noël Burtt; Jason Carey; Guillaume Charpentier; Andrew T Crenshaw; Alex S F Doney; Mozhgan Dorkhan; Sarah Edkins; Valur Emilsson; Elodie Eury; Tom Forsen; Karl Gertow; Bruna Gigante; George B Grant; Christopher J Groves; Candace Guiducci; Christian Herder; Astradur B Hreidarsson; Jennie Hui; Alan James; Anna Jonsson; Wolfgang Rathmann; Norman Klopp; Jasmina Kravic; Kaarel Krjutškov; Cordelia Langford; Karin Leander; Eero Lindholm; Stéphane Lobbens; Satu Männistö; Ghazala Mirza; Thomas W Mühleisen; Bill Musk; Melissa Parkin; Loukianos Rallidis; Jouko Saramies; Bengt Sennblad; Sonia Shah; Gunnar Sigurðsson; Angela Silveira; Gerald Steinbach; Barbara Thorand; Joseph Trakalo; Fabrizio Veglia; Roman Wennauer; Wendy Winckler; Delilah Zabaneh; Harry Campbell; Cornelia van Duijn; Andre G Uitterlinden; Albert Hofman; Eric Sijbrands; Goncalo R Abecasis; Katharine R Owen; Eleftheria Zeggini; Mieke D Trip; Nita G Forouhi; Ann-Christine Syvänen; Johan G Eriksson; Leena Peltonen; Markus M Nöthen; Beverley Balkau; Colin N A Palmer; Valeriya Lyssenko; Tiinamaija Tuomi; Bo Isomaa; David J Hunter; Lu Qi; Alan R Shuldiner; Michael Roden; Ines Barroso; Tom Wilsgaard; John Beilby; Kees Hovingh; Jackie F Price; James F Wilson; Rainer Rauramaa; Timo A Lakka; Lars Lind; George Dedoussis; Inger Njølstad; Nancy L Pedersen; Kay-Tee Khaw; Nicholas J Wareham; Sirkka M Keinanen-Kiukaanniemi; Timo E Saaristo; Eeva Korpi-Hyövälti; Juha Saltevo; Markku Laakso; Johanna Kuusisto; Andres Metspalu; Francis S Collins; Karen L Mohlke; Richard N Bergman; Jaakko Tuomilehto; Bernhard O Boehm; Christian Gieger; Kristian Hveem; Stephane Cauchi; Philippe Froguel; Damiano Baldassarre; Elena Tremoli; Steve E Humphries; Danish Saleheen; John Danesh; Erik Ingelsson; Samuli Ripatti; Veikko Salomaa; Raimund Erbel; Karl-Heinz Jöckel; Susanne Moebus; Annette Peters; Thomas Illig; Ulf de Faire; Anders Hamsten; Andrew D Morris; Peter J Donnelly; Timothy M Frayling; Andrew T Hattersley; Eric Boerwinkle; Olle Melander; Sekar Kathiresan; Peter M Nilsson; Panos Deloukas; Unnur Thorsteinsdottir; Leif C Groop; Kari Stefansson; Frank Hu; James S Pankow; Josée Dupuis; James B Meigs; David Altshuler; Michael Boehnke; Mark I McCarthy
Journal:  Nat Genet       Date:  2012-08-12       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.